Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
Rev. esp. cir. ortop. traumatol. (Ed. impr.) ; 67(5): 387-393, Sept-Oct, 2023. tab, ilus, graf
Artigo em Espanhol | IBECS | ID: ibc-224966

RESUMO

Introducción: El ácido tranexámico (ATX) tópico ha demostrado disminuir de forma significativa el sangrado en artroplastia de cadera y rodilla. A pesar de que en la artroplastia de hombro la mayoría de trabajos han demostrado su eficacia por vía intravenosa, la eficacia y dosis por vía tópica aún no está determinada. El objetivo fue comprobar si 1,5g de ATX en bajo volumen (30mL) administrado de manera tópica disminuiría el sangrado tras la artroplastia invertida de hombro (AIH). Material y métodos: Se revisaron de manera retrospectiva 177 pacientes consecutivos intervenidos de AIH por artropatía y fractura. Se recogieron datos de ΔHb y ΔHto a las 24h, débito del drenaje (mL), estancia media y complicaciones. Resultados: Los pacientes que recibieron ATX presentaron menor débito del drenaje tanto en artroplastia electiva (AIHE) (104 vs. 195mL, p=0,004) como por fractura (AIHF) (47 vs. 79mL, p=0,01). Aunque fue ligeramente menor en el grupo de ATX, no se observaron diferencias estadísticamente significativas en el sangrado sistémico (AIHE ΔHb 1,67 vs. 1,90mg/dL, AIHF 2,61 vs. 2,7mg/dL, p=0,79), estancia media (AIHE 2,0 vs. 2,3 días, p=0,34; 2,3 vs. 2,5, p=0,56) o necesidad de transfusión (0% en AIHE; AIHF 5% vs. 7%, p=0,66). Los pacientes intervenidos por fractura presentaron mayor tasa de complicaciones que aquellos que lo hicieron por artropatía (7% vs. 15,6%, p=0,04). No se observaron complicaciones asociadas al uso de ATX. Conclusión: La administración tópica de 1,5g de ATX reduce el sangrado de manera significativa en el sitio quirúrgico sin observarse complicaciones asociadas. La disminución del hematoma posquirúrgico permitiría evitar el uso sistemático de drenajes posquirúrgicos.(AU)


Introduction: Topical tranexamic acid (TXA) has been shown to decrease blood loss in knee and hip arthroplasty. Despite there is evidence about its effectiveness when administered intravenous, its effectiveness and optimal dose when used topically has not been established. We hypothesized that the use of 1.5g (30mL) of topical TXA could decrease the amount of blood loss in patients after reverse total shoulder arthroplasty (RTSA). Material and methods: One hundred and seventy-seven patients receiving a RSTA for arthropathy or fracture were retrospectively reviewed. Preoperative-to-postoperative change in hemoglobin (ΔHb) and hematocrit (ΔHct) level drain volume output, length of stay and complications were evaluated for each patient. Results: Patients receiving TXA has significant less drain output in both for arthropathy (ARSA) (104 vs. 195mL, p=0.004) and fracture (FRSA) (47 vs. 79mL, p=0.01). Systemic blood loss was slightly lower in TXA group, but this was not statistically significant (ARSA, ΔHb 1.67 vs. 1.90mg/dL, FRSA 2.61 vs. 2.7mg/dL, p=0.79). This was also observed in hospital length of stay (ARSA 2.0 vs. 2.3 days, p=0.34; 2.3 vs. 2.5, p=0.56) and need of transfusion (0% AIHE; AIHF 5% vs. 7%, p=0.66). Patients operated for a fracture had a higher rate of complications (7% vs. 15.6%, p=0.04). There were no adverse events related to TXA administration. Conclusion: Topical use of 1.5g of TXA decreases blood loss, especially on the surgical site without associated complications. Thus, hematoma decrease could avoid the systematic use of postoperative drains after reverse shoulder arthroplasty.(AU)


Assuntos
Humanos , Masculino , Feminino , Ácido Tranexâmico/efeitos adversos , Artroplastia do Ombro , Ombro/cirurgia , Fraturas do Ombro/sangue , Fraturas do Ombro/complicações , Traumatologia , Ortopedia , Procedimentos Ortopédicos , Hemorragia/tratamento farmacológico , Fraturas Ósseas/cirurgia , Estudos Retrospectivos
2.
Rev. esp. cir. ortop. traumatol. (Ed. impr.) ; 67(5): T387-T393, Sept-Oct, 2023. tab, ilus, graf
Artigo em Inglês | IBECS | ID: ibc-224967

RESUMO

Introducción: El ácido tranexámico (ATX) tópico ha demostrado disminuir de forma significativa el sangrado en artroplastia de cadera y rodilla. A pesar de que en la artroplastia de hombro la mayoría de trabajos han demostrado su eficacia por vía intravenosa, la eficacia y dosis por vía tópica aún no está determinada. El objetivo fue comprobar si 1,5g de ATX en bajo volumen (30mL) administrado de manera tópica disminuiría el sangrado tras la artroplastia invertida de hombro (AIH). Material y métodos: Se revisaron de manera retrospectiva 177 pacientes consecutivos intervenidos de AIH por artropatía y fractura. Se recogieron datos de ΔHb y ΔHto a las 24h, débito del drenaje (mL), estancia media y complicaciones. Resultados: Los pacientes que recibieron ATX presentaron menor débito del drenaje tanto en artroplastia electiva (AIHE) (104 vs. 195mL, p=0,004) como por fractura (AIHF) (47 vs. 79mL, p=0,01). Aunque fue ligeramente menor en el grupo de ATX, no se observaron diferencias estadísticamente significativas en el sangrado sistémico (AIHE ΔHb 1,67 vs. 1,90mg/dL, AIHF 2,61 vs. 2,7mg/dL, p=0,79), estancia media (AIHE 2,0 vs. 2,3 días, p=0,34; 2,3 vs. 2,5, p=0,56) o necesidad de transfusión (0% en AIHE; AIHF 5% vs. 7%, p=0,66). Los pacientes intervenidos por fractura presentaron mayor tasa de complicaciones que aquellos que lo hicieron por artropatía (7% vs. 15,6%, p=0,04). No se observaron complicaciones asociadas al uso de ATX. Conclusión: La administración tópica de 1,5g de ATX reduce el sangrado de manera significativa en el sitio quirúrgico sin observarse complicaciones asociadas. La disminución del hematoma posquirúrgico permitiría evitar el uso sistemático de drenajes posquirúrgicos.(AU)


Introduction: Topical tranexamic acid (TXA) has been shown to decrease blood loss in knee and hip arthroplasty. Despite there is evidence about its effectiveness when administered intravenous, its effectiveness and optimal dose when used topically has not been established. We hypothesized that the use of 1.5g (30mL) of topical TXA could decrease the amount of blood loss in patients after reverse total shoulder arthroplasty (RTSA). Material and methods: One hundred and seventy-seven patients receiving a RSTA for arthropathy or fracture were retrospectively reviewed. Preoperative-to-postoperative change in hemoglobin (ΔHb) and hematocrit (ΔHct) level drain volume output, length of stay and complications were evaluated for each patient. Results: Patients receiving TXA has significant less drain output in both for arthropathy (ARSA) (104 vs. 195mL, p=0.004) and fracture (FRSA) (47 vs. 79mL, p=0.01). Systemic blood loss was slightly lower in TXA group, but this was not statistically significant (ARSA, ΔHb 1.67 vs. 1.90mg/dL, FRSA 2.61 vs. 2.7mg/dL, p=0.79). This was also observed in hospital length of stay (ARSA 2.0 vs. 2.3 days, p=0.34; 2.3 vs. 2.5, p=0.56) and need of transfusion (0% AIHE; AIHF 5% vs. 7%, p=0.66). Patients operated for a fracture had a higher rate of complications (7% vs. 15.6%, p=0.04). There were no adverse events related to TXA administration. Conclusion: Topical use of 1.5g of TXA decreases blood loss, especially on the surgical site without associated complications. Thus, hematoma decrease could avoid the systematic use of postoperative drains after reverse shoulder arthroplasty.(AU)


Assuntos
Humanos , Ácido Tranexâmico/efeitos adversos , Artroplastia do Ombro , Ombro/cirurgia , Fraturas do Ombro/sangue , Fraturas do Ombro/complicações , Traumatologia , Ortopedia , Procedimentos Ortopédicos , Hemorragia/tratamento farmacológico , Fraturas Ósseas/cirurgia , Estudos Retrospectivos
3.
Rev Esp Cir Ortop Traumatol ; 67(5): T387-T393, 2023.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-37311478

RESUMO

INTRODUCTION: Topical tranexamic acid (TXA) has been shown to decrease blood loss in knee and hip arthroplasty. Despite there is evidence about its effectiveness when administered intravenous, its effectiveness and optimal dose when used topically have not been established. We hypothesised that the use of 1.5g (30mL) of topical TXA could decrease the amount of blood loss in patients after reverse total shoulder arthroplasty (RTSA). MATERIAL AND METHODS: One hundred and seventy-seven patients receiving a RSTA for arthropathy or fracture were retrospectively reviewed. Preoperative-to-postoperative change in haemoglobin (ΔHb) and hematocrit (ΔHct) level drain volume output, length of stay and complications were evaluated for each patient. RESULTS: Patients receiving TXA has significant less drain output in both for arthropathy (ARSA) (104 vs. 195mL, p=0.004) and fracture (FRSA) (47 vs. 79mL, p=0.01). Systemic blood loss was slightly lower in TXA group, but this was not statistically significant (ARSA, ΔHb 1.67 vs. 1.90mg/dL, FRSA 2.61 vs. 2.7mg/dL, p=0.79). This was also observed in hospital length of stay (ARSA 2.0 vs. 2.3 days, p=0.34; 2.3 vs. 2.5, p=0.56) and need of transfusion (0% AIHE; AIHF 5% vs. 7%, p=0.66). Patients operated for a fracture had a higher rate of complications (7% vs. 15.6%, p=0.04). There were no adverse events related to TXA administration. CONCLUSION: Topical use of 1.5g of TXA decreases blood loss, especially on the surgical site without associated complications. Thus, haematoma decrease could avoid the systematic use of postoperative drains after reverse shoulder arthroplasty.

4.
Rev Esp Cir Ortop Traumatol ; 67(5): 387-393, 2023.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-37054841

RESUMO

INTRODUCTION: Topical tranexamic acid (TXA) has been shown to decrease blood loss in knee and hip arthroplasty. Despite there is evidence about its effectiveness when administered intravenous, its effectiveness and optimal dose when used topically has not been established. We hypothesized that the use of 1.5g (30mL) of topical TXA could decrease the amount of blood loss in patients after reverse total shoulder arthroplasty (RTSA). MATERIAL AND METHODS: One hundred and seventy-seven patients receiving a RSTA for arthropathy or fracture were retrospectively reviewed. Preoperative-to-postoperative change in hemoglobin (ΔHb) and hematocrit (ΔHct) level drain volume output, length of stay and complications were evaluated for each patient. RESULTS: Patients receiving TXA has significant less drain output in both for arthropathy (ARSA) (104 vs. 195mL, p=0.004) and fracture (FRSA) (47 vs. 79mL, p=0.01). Systemic blood loss was slightly lower in TXA group, but this was not statistically significant (ARSA, ΔHb 1.67 vs. 1.90mg/dL, FRSA 2.61 vs. 2.7mg/dL, p=0.79). This was also observed in hospital length of stay (ARSA 2.0 vs. 2.3 days, p=0.34; 2.3 vs. 2.5, p=0.56) and need of transfusion (0% AIHE; AIHF 5% vs. 7%, p=0.66). Patients operated for a fracture had a higher rate of complications (7% vs. 15.6%, p=0.04). There were no adverse events related to TXA administration. CONCLUSION: Topical use of 1.5g of TXA decreases blood loss, especially on the surgical site without associated complications. Thus, hematoma decrease could avoid the systematic use of postoperative drains after reverse shoulder arthroplasty.

5.
Injury ; 54 Suppl 7: 111042, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38225161

RESUMO

OBJECTIVE: The aim of this study was to analyze the outcomes and complications of minimally invasive plate osteosynthesis (MIPO) for displaced proximal humerus fractures and elucidate if the percutaneous technique reduces the rate of avascular necrosis (AVN) without jeopardizing fracture reduction. MATERIAL AND METHODS: 118 patients with a displaced proximal humerus fracture were treated with a polyaxial locking-plate through a standardized percutaneous approach. 73 % were women and mean age was 63 years (18-89) with an average follow-up of 51 months (12-256). There were 32 two-part fractures (27 %), 57 three-part fractures (48 %) and 24 four-part fractures (25 %). Shoulder function at the last follow-up, including ROM and ability to perform daily living activities, was objectively evaluated with an adjusted Constant Score (CS). Subjective patient satisfaction was rated with an Visual Analogic Scale from 0 to 10 and the degree of residual pain with a Verbal Rating Scale (VRS). Radiographic analysis at the most recent follow-up evaluated the presence of AVN, degree of residual medial calcar displacement, and the cervicodiaphiseal angle. RESULTS: Forty patients (34 %) had a complication, 25 of them (21 %) requiring further surgery. ROM at the last follow-up was 131° of elevation (40°-180°), 38° of external rotation (SD: 17.7) and internal rotation to L3. Average adjusted Constant Score was 68 (SD: 17.76). Twenty-one patients (18 %) complained of shoulder pain (14 moderate and 7 severe) and seven were not satisfied. Radiographically, 29 patients (25 %) had varus malunion and 17 patients (14 %) showed some degree of AVN. Patients with varus malunion (CS 64.3 versus 69.8, p = 0.16) and AVN (CS 56.9 versus 70.4, p = 0.005) had lower CS. The presence of a varus malunion was directly related to the degree of initial medial calcar displacement (p = 0.001) and deficient calcar reduction at surgery (p = 0.004). AVN was statistically more prevalent when the medial calcar was inadequately reduced (p = 0.01). CONCLUSIONS: MIPO surgery for proximal humerus fractures through an anterolateral approach does not reduce the rate of mechanical complications or AVN compared with standard ORIF techniques. Moreover, percutaneous plating may preclude adequate medial calcar reduction, leading to humeral head malunion and a worse clinical outcome.


Assuntos
Fraturas do Úmero , Fraturas do Ombro , Humanos , Feminino , Pessoa de Meia-Idade , Masculino , Fixação Interna de Fraturas/métodos , Fixação de Fratura , Úmero/cirurgia , Cabeça do Úmero , Fraturas do Ombro/diagnóstico por imagem , Fraturas do Ombro/cirurgia , Placas Ósseas , Estudos Retrospectivos , Resultado do Tratamento
6.
EFORT Open Rev ; 7(10): 727-733, 2022 Oct 26.
Artigo em Inglês | MEDLINE | ID: mdl-36287106

RESUMO

Purpose: The aim of this study was to systematically review clinical studies on the employed definitions of longitudinal forearm instabilities referred to as Essex-Lopresti (EL) injuries, interosseous membrane (IOM) injuries or longitudinal radioulnar dissociation. Methods: A systematic literature search was performed in MEDLINE, Embase, CINAHL, Web of Science and Cochrane databases, adhering to PRISMA guidelines. All data on diagnosis and treatment were collected. Results: In total, 47 clinical studies involving 266 patients were included. Thirty-nine of 47 studies did not mention an IOM lesion as part of the EL injury. The amount of preoperative positive ulnar variance varied from >1 to >12 mm. Nine studies used some form of dynamic pre-operative or intraoperative test of longitudinal radioulnar instability. Conclusions: There is no accepted definition of EL injury in the literature. In order to prevent underdetection of acute EL injury, a radial head fracture in a patient with wrist and/or forearm pain should raise awareness of the possibility of an EL injury. In this case, comparative radiographic studies and some form of dynamic assessment of longitudinal radioulnar stability should be performed.

7.
O.F.I.L ; 32(1): 29-33, enero 2022. tab
Artigo em Espanhol | IBECS | ID: ibc-205728

RESUMO

El objetivo de este trabajo es evaluar el tratamiento antidiabético y la concordancia con los valores de hemoglobina glicosilada (HbA1c) recomendados por la guías en pacientes ancianos: entre 7,5 y 8,5% para el control de la diabetes mellitus tipo II (DMII) en el paciente anciano frágil, relacionándose HbA1c <6,5% con mayor morbi-mortalidad, riesgo de hipoglucemias y caídas.Se trata de un estudio retrospectivo realizado en enero 2020. Se incluyeron pacientes diagnosticados de DMII, mayores de 75 años, que llevaran tratamiento con cualquier combinación de antidiabéticos orales (ADO). Se registró el último valor de HbA1c disponible durante el año previo. Se analizó la relación entre el valor de HbA1c y el número de ADOs prescritos (+ insulina), edad del paciente y/o fragilidad. Se incluyeron 936 pacientes, edad media 81,3 años. El 15,8% de los pacientes no tenía ninguna determinación de HbA1c disponible en el último año. El resto de pacientes, tenían una media de HbA1c de 6,6%. Sólo el 13,2% de los pacientes se situaron en el intervalo terapéutico objetivo (7,5-8,5%). Un 39,9% tuvo una HbA1c <6,5% y solamente un 5,0% tenía un HbA1c ≥8,5%, (mal control). De los 617 pacientes con una HbA1c <7,5%, el 25,4% eran mayores de 85 años, el 32,1% estaban clasificados como paciente crónico complejo (PCC), lo que suponía una mayor fragilidad, el 38,6% llevaban más de un fármaco ADO y el 8,6% llevaba asociada insulina.Los valores de HbA1c en los pacientes ancianos analizados son inferiores a los recomendados por las principales guías. Los resultados de este trabajo hacen patente la necesidad de implementar estrategias que permitan establecer el tratamiento óptimo de manera individualizada. (AU)


The objective of this work is to evaluate antidiabetic treatment and concordance with the glycosylated hemoglobin (HbA1c) values recommended by the guidelines in elderly patients: between 7.5 and 8.5% for the control of type II diabetes mellitus (DMII) in frail elderly patients. HbA1c <6.5% is being associated with higher morbidity and mortality, risk of hypoglycemia and falls.This is a retrospective study conducted in January 2020. Patients diagnosed with DMII, older than 75 years, who had been treated with any combination of oral antidiabetic drugs (ADO) were included. The last HbA1c value available during the previous year was recorded. The relationship between the HbA1c value and the number of prescribed ADOs (+ insulin), age of the patient and/or frailty was analyzed.936 patients were included, mean age 81.3 years. 15.8% of the patients had no HbA1c determination available in the last year. The rest of the patients had a mean HbA1c of 6.6%. Only 13.2% of the patients were in the target therapeutic range (7.5-8.5%). 39.9% had an HbA1c <6.5% and only 5.0% had an HbA1c ≥8.5%, (poor control). Of the 617 patients with an HbA1c <7.5%, 25.4% were older than 85 years, 32.1% were classified as complex chronic patient (PCC), which meant greater frailty, 38.6% had more than one ADO drug and 8.6% had associated insulin.The HbA1c values in the analyzed elderly patients are lower than those recommended by the main guidelines. The results of this work make clear the need to implement strategies that establish the optimal treatment individually. (AU)


Assuntos
Humanos , Idoso , Diabetes Mellitus Tipo 2 , Idoso , Indicadores de Morbimortalidade , Terapêutica
8.
Shoulder Elbow ; 12(3): 212-223, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32565923

RESUMO

The shape and size of the radial head is highly variable but correlates to the contralateral side. The radial head is a secondary stabilizer to valgus stress and provides lateral stability. The modified Mason-Hotchkiss classification is the most commonly used and describes three types, depending on the number of fragments and their displacement. Type 1 fractures are typically treated conservatively. Surgical reduction and fixation are recommended for type 2 fractures, if there is a mechanical block to motion. This can be done arthroscopically or open. Controversy exists for two-part fractures with >2 mm and <5 mm displacement, without a mechanical bloc as good results have been published with conservative treatment. Type 3 fractures are often treated with radial head replacement. Although radial head resection is also an option as long-term results have been shown to be favourable. Radial head arthroplasty is recommended in type 3 fractures with ligamentous injury or proximal ulna fractures. Failure of primary radial head replacement may be due to several factors. Identification of the cause of failure is essential. Failed radial head arthroplasty can be treated by implant removal alone, interposition arthroplasty, revision radial head replacement either as a single stage or two-stage procedure.

9.
mBio ; 11(1)2020 01 14.
Artigo em Inglês | MEDLINE | ID: mdl-31937639

RESUMO

Genus assignment is fundamental in the characterization of microbes, yet there is currently no unambiguous way to demarcate genera solely using standard genomic relatedness indices. Here, we propose an approach to demarcate genera that relies on the combined use of the average nucleotide identity, genome alignment fraction, and the distinction between type- and non-type species. More than 3,500 genomes representing type strains of species from >850 genera of either bacterial or archaeal lineages were tested. Over 140 genera were analyzed in detail within the taxonomic context of order/family. Significant genomic differences between members of a genus and type species of other genera in the same order/family were conserved in 94% of the cases. Nearly 90% (92% if polyphyletic genera are excluded) of the type strains were classified in agreement with current taxonomy. The 448 type strains that need reclassification directly impact 33% of the genera analyzed in detail. The results provide a first line of evidence that the combination of genomic indices provides added resolution to effectively demarcate genera within the taxonomic framework that is currently based on the 16S rRNA gene. We also identify the emergence of natural breakpoints at the genome level that can further help in the circumscription of taxa, increasing the proportion of directly impacted genera to at least 43% and pointing at inaccuracies on the use of the 16S rRNA gene as a taxonomic marker, despite its precision. Altogether, these results suggest that genomic coherence is an emergent property of genera in Bacteria and ArchaeaIMPORTANCE In recent decades, the taxonomy of Bacteria and Archaea, and therefore genus designation, has been largely based on the use of a single ribosomal gene, the 16S rRNA gene, as a taxonomic marker. We propose an approach to delineate genera that excludes the direct use of the 16S rRNA gene and focuses on a standard genome relatedness index, the average nucleotide identity. Our findings are of importance to the microbiology community because the emergent properties of Bacteria and Archaea that are identified in this study will help assign genera with higher taxonomic resolution.


Assuntos
Archaea/classificação , Bactérias/classificação , Classificação/métodos , Genoma Arqueal , Genoma Bacteriano , DNA Bacteriano/genética , Genômica , Filogenia , RNA Ribossômico 16S/genética , Análise de Sequência de DNA
10.
Rev. Esp. Cir. Ortop. Traumatol. (Ed. Impr.) ; 59(5): 354-359, sept.-oct. 2015.
Artigo em Espanhol | IBECS | ID: ibc-140877

RESUMO

Objetivo. El propósito de este estudio es evaluar la validez interna de una prueba clínica descrita para el diagnóstico precoz de la capsulitis adhesiva de hombro: el Test de Distensión en Rotación Externa Pasiva (TDREP). Material y método. El TDREP se realiza con el paciente de pie, el brazo adducido y el codo flexionado a 90°. Desde esta posición, se inicia un movimiento suave de rotación externa pasiva, sosteniendo el brazo afectado con una mano del examinador en la muñeca y otra manteniendo el codo abducido hasta que se alcanza el punto máximo de rotación indolora. Desde este punto de máxima rotación externa con el brazo en aducción y sin dolor, se realiza un movimiento brusco de distensión, incrementando la rotación externa, causando dolor en el hombro si la prueba es positiva. Es test se realizó en un grupo de 155 pacientes con dolor de hombro de múltiples orígenes para analizar los valores predictivos, la sensibilidad, especificidad y razón de verosimilitud. Resultados. El TDREP mostró una sensibilidad de 100% (IC 95%, de 91,8 a 100%) y una especificidad del 90% (IC 95%, de 82,4 a 94,8%). El valor predictivo positivo fue de 0,62 y la razón de verosimilitud de 10,22 (IC 95%: 5,5 a 19,01). Los falsos positivos se encontraron solo en enfermos con tendinopatías del subescapular o con artrosis glenohumeral. Discusión. El TDREP tiene una alta sensibilidad para diagnosticar CA y cuando es negativo prácticamente la excluye. Los falsos positivos se pueden identificar fácilmente si existe una rotación externa sin limitación (tendinopatía subescapular) o con una radiografía simple de hombro (artrosis glenohumeral) (AU)


Objective. The aim of this study is to evaluate the internal validity of a clinical test for the early diagnosis of shoulder adhesive capsulitis, called the Distension Test in Passive External Rotation (DTPER). Material and method. The DTPER is performed with the patient standing up, the arm adducted, and the elbow bent at 90°. From this position, a smooth passive external rotation is started, the affected arm being supporting at the wrist with one hand of the examiner and the other maintaining the adducted elbow until the maximum painless point of the rotation is reached. From this point of maximum external rotation with the arm in adduction and with no pain, an abrupt distension movement is made, increasing the external rotation, causing pain in the shoulder if the test is positive. This term was performed on a group of patients with shoulder pain of many origins, in order to analyse the predictive values, sensitivity, specificity, and the likelihood ratio. Results. The DTPER showed a sensitivity of 100% (95% CI; 91.8 to 100%) and a specificity of 90% (95% CI; 82.4 to 94.8%). The positive predictive value was 0.62 and a likelihood ratio of 10.22 (95% CI; 5.5 to 19.01). False positives were only found in patients with subscapular tendinopathies or glenohumeral arthrosis. Discussion. The DTPER has a high sensitivity for the diagnosis of adhesive capsulitis, and is excluded when it is practically negative. False positives can easily be identified if there is external rotation with no limits (subscapular tendinopathy) or with a simple shoulder X-ray (glenohumeral arthrosis) (AU)


Assuntos
Bursite/complicações , Bursite/diagnóstico , Diagnóstico Precoce , Valor Preditivo dos Testes , Tendinopatia/complicações , Tendinopatia/diagnóstico , Ombro/patologia , Ombro/cirurgia , Ombro , Sensibilidade e Especificidade , Escápula/patologia , Articulação do Ombro/patologia , Articulação do Ombro , Imageamento por Ressonância Magnética/métodos
11.
Rev. esp. cir. ortop. traumatol. (Ed. impr.) ; 59(1): 3-8, ene.-feb. 2015. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-132371

RESUMO

Objetivo. La reparación del manguito rotador tiene una alta tasa de fracaso. Se investiga si la aplicación de células troncales derivadas de lipoaspirado mejorará la resistencia de la reparación y recreará la entesis original. Material y métodos. Estudio experimental en 44 ratas BDIX con sección y reparación con sutura del tendón supraespinoso y asignación aleatoria a uno de 3 grupos: grupo A, nada (control); grupo B, aplicación local de vehículo de fibrina; y grupo C, aplicación de 2 x 106 células troncales derivadas de lipoaspirado. Se realiza estudio mecánico en célula de carga y estudio histológico en hematoxilina-eosina. Resultados. En el estudio mecánico no hubo diferencias entre grupos. La carga hasta el fracaso aumentó de los grupos de 4-8 semanas. En el estudio histológico se observó la unión hueso-tendón mediante un tejido fibrovascular desorganizado. En el grupo C se observó un aumento de células plasmáticas a las 4 y 8 semanas. Conclusión. La utilización de células troncales derivadas de lipoaspirado no recrea la organización celular de la entesis ni mejoran las propiedades biomecánicas de la misma. Son necesarios más estudios para investigar técnicas que mejoren la cicatrización del tendón (AU)


Aim. Rotator cuff repairs have shown a high level of re-ruptures. We hypothesized that the use of adipose-derived stem cells (ASC) could improve the biomechanical and histological properties of the repair. Material and methods. Controlled experimental study conducted on 44 BDIX rats with section and repair of the supraspinatus tendon and randomization to one of three groups: group A, no intervention (control); group B, local applications of a fibrin sealant; and group C, application of the fibrin sealant with 2 x 106 ASC. At 4 and 8 weeks a biomechanical and histological analysis was performed. Results. There were no differences in load-to-failure at 4 and 8 weeks between groups. The load-to-failure did increase between week 4 and week 8. Histologically the tendon-to bone union showed a disorganized fibrovascular tissue. Group C showed a different inflammatory pattern, with less presence of neutrophils and more presence of plasma cells. Conclusion. The use of ASC does not improve the biomechanical or histological properties of the repair site. More studies are needed to improve techniques that enhance the healing site of the repair (AU)


Assuntos
Animais , Masculino , Feminino , Ratos , Pesquisa com Células-Tronco , Células-Tronco , Manguito Rotador/patologia , Manguito Rotador/cirurgia , Modelos Animais , Consolidação da Fratura , Procedimentos Ortopédicos , Procedimentos Ortopédicos/veterinária , Suturas , Suturas/veterinária , Técnicas de Sutura , Técnicas de Sutura/veterinária , Síndrome de Colisão do Ombro/cirurgia , Síndrome de Colisão do Ombro/veterinária
12.
Rev Esp Cir Ortop Traumatol ; 59(1): 3-8, 2015.
Artigo em Espanhol | MEDLINE | ID: mdl-25242729

RESUMO

AIM: Rotator cuff repairs have shown a high level of re-ruptures. We hypothesized that the use of adipose-derived stem cells (ASC) could improve the biomechanical and histological properties of the repair. MATERIAL AND METHODS: Controlled experimental study conducted on 44 BDIX rats with section and repair of the supraspinatus tendon and randomization to one of three groups: group A, no intervention (control); group B, local applications of a fibrin sealant; and group C, application of the fibrin sealant with 2 x 10(6) ASC. At 4 and 8 weeks a biomechanical and histological analysis was performed. RESULTS: There were no differences in load-to-failure at 4 and 8 weeks between groups. The load-to-failure did increase between week 4 and week 8. Histologically the tendon-to bone union showed a disorganized fibrovascular tissue. Group C showed a different inflammatory pattern, with less presence of neutrophils and more presence of plasma cells. CONCLUSION: The use of ASC does not improve the biomechanical or histological properties of the repair site. More studies are needed to improve techniques that enhance the healing site of the repair.


Assuntos
Transplante de Células-Tronco Mesenquimais/métodos , Lesões do Manguito Rotador , Gordura Subcutânea/citologia , Traumatismos dos Tendões/terapia , Animais , Terapia Combinada , Adesivo Tecidual de Fibrina/uso terapêutico , Distribuição Aleatória , Ratos , Resultado do Tratamento
13.
Rev Esp Cir Ortop Traumatol ; 59(5): 354-9, 2015.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-25544715

RESUMO

OBJECTIVE: The aim of this study is to evaluate the internal validity of a clinical test for the early diagnosis of shoulder adhesive capsulitis, called the Distension Test in Passive External Rotation (DTPER). MATERIAL AND METHOD: The DTPER is performed with the patient standing up, the arm adducted, and the elbow bent at 90°. From this position, a smooth passive external rotation is started, the affected arm being supporting at the wrist with one hand of the examiner and the other maintaining the adducted elbow until the maximum painless point of the rotation is reached. From this point of maximum external rotation with the arm in adduction and with no pain, an abrupt distension movement is made, increasing the external rotation, causing pain in the shoulder if the test is positive. This term was performed on a group of patients with shoulder pain of many origins, in order to analyse the predictive values, sensitivity, specificity, and the likelihood ratio. RESULTS: The DTPER showed a sensitivity of 100% (95% CI; 91.8 to 100%) and a specificity of 90% (95% CI; 82.4 to 94.8%). The positive predictive value was 0.62 and a likelihood ratio of 10.22 (95% CI; 5.5 to 19.01). False positives were only found in patients with subscapular tendinopathies or glenohumeral arthrosis. DISCUSSION: The DTPER has a high sensitivity for the diagnosis of adhesive capsulitis, and is excluded when it is practically negative. False positives can easily be identified if there is external rotation with no limits (subscapular tendinopathy) or with a simple shoulder X-ray (glenohumeral arthrosis).


Assuntos
Bursite/diagnóstico , Amplitude de Movimento Articular , Rotação , Articulação do Ombro/fisiopatologia , Adulto , Idoso , Bursite/fisiopatologia , Diagnóstico Precoce , Reações Falso-Positivas , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade
14.
15.
Geobiology ; 12(2): 146-56, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24428517

RESUMO

Iron (Fe)-oxidizing bacteria have the potential to produce morphologically unique structures that may be used as biosignatures in geological deposits. One particular example is Mariprofundus ferrooxydans, which produces extracellular twisted ribbon-like stalks consisting of ferrihydrite, co-located with organic and inorganic elements. It is currently thought that M. ferrooxydans excrete and co-precipitate polysaccharides and Fe simultaneously; however, the cellular production of these polysaccharides has yet to be confirmed. Here, we report on a time-series study that used scanning transmission X-ray microscopy and C 1s and Ca 2p near-edge X-ray adsorption fine structure spectroscopy to investigate production of polysaccharides over the growth cycle of M. ferrooxydans. The production and morphology of twisted iron stalks were consistent with previous observations, but unexpectedly, in the log phase, the carbon content of the stalks was extremely low. It was not until stationary growth phase that a significant component of carbon was detected on the stalks. During the log phase, low levels of carbon, only detectable when the stalks were thin, suggested that M. ferrooxydans produce an extracellular polysaccharide template onto which the Fe precipitates. By stationary phase, the increased carbon association with the stalks was a result of adsorption of organic compounds that were released during osmotic shock post-stalk production. In the environment, elevated concentrations of DOC could adsorb onto the Fe stalks as well as a number of other elements, for example, Si, P, Ca, which, by preventing chemical interactions between the Fe nanoparticles, will prevent structural deformation during recrystallization and preserve the structure of these filaments in the rock record.


Assuntos
Compostos Férricos/metabolismo , Ferro/metabolismo , Polissacarídeos/metabolismo , Proteobactérias/metabolismo , Carbono/metabolismo , Microscopia Eletrônica de Transmissão e Varredura , Oxirredução , Espectroscopia por Absorção de Raios X
16.
J Phys Condens Matter ; 24(4): 046002, 2012 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-22214606

RESUMO

The magnetization of the sigma-phase Fe(0.53)Cr(0.47) and Fe(0.52)V(0.48) alloys was studied as a function of temperature and field. The experiments show that both materials behave magnetically as re-entrant spin glass systems. Field versus temperature diagrams were obtained where the locations of the paramagnetic phase, the intermediate ferromagnetic-like phase and the spin glass fundamental state were displayed. These diagrams are in qualitative agreement with the predictions of the mean field theory for the interplay between the ferromagnetic and spin glass orderings. The critical phenomenology near the para-ferromagnetic transition could be investigated. It was found that the paramagnetic susceptibility is quite well described by the extended scaling scheme, where the reduced temperature is written as τ = (T - T(c))/T. The value obtained for the susceptibility critical exponent γ is intermediate between the prediction of the 3D Heisenberg universality class and the large values observed in spin glasses, as previously found in other re-entrant systems. The data do not confirm the validity of the extended scaling in the ferromagnetic-like phase. Using either the conventional or extended scaling protocols, the exponents ß and δ were found to have values close to those reported for spin glass transitions. Despite the relevance of disorder and the anomalous values determined for ß, γ and δ, the Widom scaling relation holds as an equality.

17.
Injury ; 43 Suppl 2: S7-11, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23622997

RESUMO

The purpose of this study was to evaluate the poly-axial locked plating system inserted through a minimally invasive approach for the treatment of three-part fractures of the proximal humerus. Twenty-three patients with a three-part fracture of the proximal humerus treated with a poly-axial locking plate through a percutaneous approach were available for clinical and radiological analysis at a minimum of 2 years follow up (average 36 months; range, 24-54 months). To assess objective and subjective outcomes the Constant Score (CS) and the Disabilities of the Arm, Shoulder, and Hand (DASH) score were obtained. All complications were recorded. There were 17 women and 6 men, with a mean age of 62 years (range, 18-86). All fractures healed. At final follow up, the mean forward flexion, external rotation and internal rotation were 126°, 44° and L1, respectively; the mean CS was 64 and the mean DASH score was 23. Twelve patients (52%) had a postoperative complication, which included screw cut-out, stiffness and infection. The poly-axial locked plating system through a minimally-invasive approach may be an appropriate treatment for three-part fractures of the proximal humerus and may reduce the biological aggression of conventional plate fixation.


Assuntos
Placas Ósseas , Parafusos Ósseos , Fixação de Fratura/métodos , Complicações Pós-Operatórias/cirurgia , Fraturas do Ombro/cirurgia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Avaliação da Deficiência , Desenho de Equipamento , Feminino , Seguimentos , Consolidação da Fratura , Humanos , Escala de Gravidade do Ferimento , Masculino , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Minimamente Invasivos , Satisfação do Paciente , Complicações Pós-Operatórias/diagnóstico por imagem , Complicações Pós-Operatórias/fisiopatologia , Radiografia , Amplitude de Movimento Articular , Medição de Risco , Fraturas do Ombro/diagnóstico por imagem , Fraturas do Ombro/fisiopatologia , Inquéritos e Questionários , Fatores de Tempo , Resultado do Tratamento
19.
Rev. esp. cir. ortop. traumatol. (Ed. impr.) ; 55(4): 282-287, jul.-ago. 2011.
Artigo em Espanhol | IBECS | ID: ibc-89767

RESUMO

Objetivo. El objetivo de este trabajo es investigar si la aplicación de plasma rico en plaquetas con alto contenido en fibrina a la zona de reparación de roturas masivas del manguito de los rotadores tratadas mediante técnicas artroscópicas mejora los resultados funcionales y disminuye el índice de reroturas. Material y método. 28 enfermos (20 mujeres y 8 varones) con una edad media de 65 años (rango: 53 a 78) diagnosticados de una rotura masiva del manguito rotador (dos tendones afectados>5cm) fueron incluidos en este estudio prospectivo y aleatorizado. En todos los enfermos se realizó una reparación completa artroscópica del manguito rotador con técnica de una hilera. En 14 pacientes una vez finalizada la reparación se aplicó en la zona de transición osteotendinosa un concentrado de plasma rico en plaquetas y alto contenido de fibrina, mientras que en 14 enfermos se realizó la reparación sin ningún aporte de factores de crecimiento. Se evaluaron los resultados funcionales con la escala de Constant al año de la intervención, así como una artro-RM para comprobar la integridad del tendón reparado. Resultados. No hubo complicaciones ni reoperaciones en ninguno de los dos grupos. El Constant preoperatorio mejoró 30 puntos en el grupo sin PRP y 26 puntos en el grupo con PRP, sin diferencias entre ambos grupos. En el estudio de artro-RM 9 pacientes mostraban integridad de la reparación (32%), 4 presentaban una fuga de contraste y 15 una rerotura franca. No se encontraron diferencias en índice de reroturas entre el grupo en el que se aplicó plasma rico en plaquetas y en el que no. Conclusiones. La reparación artroscópica de roturas masivas del manguito rotador ofrece unos resultados clínicos satisfactorios a pesar de un elevado índice de nuevas roturas. La aplicación de plasma rico en plaquetas no mejora los resultados clínicos ni disminuye el índice de reroturas (AU)


Objective. The aim of this work is to investigate whether the application of platelet-rich plasma (PRP) with a high fibrin content in the repair area of massive rotator cuff tears treated using arthroscopic techniques improves the functional results and decreases the number of re-tears. Material and method. This prospective, randomised study included 28 patients (20 females and 8 males) with a mean age of 65 years (range: 53 to 78) and diagnosed with a massive rotator cuff tear (two tendons affected, >5cm). A complete single row arthroscopic repair of the rotator cuff was performed on all patients. A concentrate of platelet rich plasma with a high fibrin content was applied to the osteotendinous transition area in 14 patients after the operation, whilst in the other 14 patients the repair was performed without any growth factor support. The functional results were evaluated with the Constant scale, as well as an arthro-MRI to check the integrity of the repaired tendon one year after the operation. Results. There were no complications or repeat operations in any of the two groups. The pre-operative Constant results improved 30 points in the group without PRP and 26 points in the group with PRP, with no significant differences between both groups. In the arthro-MRI study, integrity of the repair was observed in 9 (32%) patients, whilst 4 had a contrast leak and 15 a clear re-tear. No differences were found in the number of re-tears between the group in which the platelet-rich plasma was applied and in the one where it was not applied. Conclusions. The arthroscopic repair of massive rotator cuff tears gives clinically satisfactory results, despite a high rate of new tears. The application of platelet-rich plasma did not improve the clinic results or decrease the number of re-tears (AU)


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Manguito Rotador/cirurgia , Artroscopia , Plasma Rico em Plaquetas/metabolismo , Plasma Rico em Plaquetas/fisiologia , Fibrina/uso terapêutico , Antibioticoprofilaxia/métodos , Antibioticoprofilaxia/tendências , Estudos Prospectivos , Manguito Rotador , Intervalos de Confiança
20.
Oncogene ; 25(26): 3661-9, 2006 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-16462762

RESUMO

Localization of beta-catenin in the cell is a key determinant in its decision to function as a critical mediator of cell adhesion at the surface or a transcription activator in the nucleus. SYT-SSX2 is the fusion product of the chromosomal translocation, t(X;18)(p11.2;q11.2), which occurs in synovial sarcoma, a soft tissue tumor. SYT-SSX2 is known to associate with chromatin remodeling complexes and is proposed to be involved in controlling gene expression. We report that SYT-SSX2 plays a direct role in beta-catenin regulation. When expressed in mammalian cells, SYT-SSX2-induced beta-catenin recruitment to the nucleus. Interestingly, known target genes of canonical Wnt were not activated as a result of SYT-SSX2 expression, nor was the nuclear localization of beta-catenin due to one of the signaling pathways normally implicated in this event. beta-Catenin accumulation in the nucleus led to the formation of a transcriptionally active nuclear complex that contained SYT-SSX2 and beta-catenin. More importantly, depletion of SYT-SSX2 in primary synovial sarcoma cells resulted in loss of nuclear beta-catenin signal and a significant decrease in its signaling activity. These results unravel a novel pathway in the control of beta-catenin cellular transport and strongly suggest that SYT-SSX2 contributes to tumor development, in part through beta-catenin signaling.


Assuntos
Núcleo Celular/metabolismo , Proteínas de Fusão Oncogênica/metabolismo , beta Catenina/metabolismo , Transporte Ativo do Núcleo Celular , Animais , Núcleo Celular/genética , Ciclina D1/metabolismo , Proteína p300 Associada a E1A/metabolismo , Inibidores Enzimáticos/farmacologia , Humanos , Camundongos , Complexos Multiproteicos , Proteínas de Fusão Oncogênica/genética , Sarcoma Sinovial/genética , Sarcoma Sinovial/metabolismo , Transdução de Sinais/efeitos dos fármacos , Células Tumorais Cultivadas , beta Catenina/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...